Recent NTLA Stock Price | NTLA Stock Predictions | |
$15.73 | +274.32% |
$58.88 |
Recent NTLA Analyst Ratings Breakdown, Making NTLA Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 19 | 19 | 19 | 19 |
Buy ratings: | 2 | 2 | 2 | 2 |
Hold ratings: | 6 | 6 | 6 | 6 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.52 | 1.52 | 1.52 | 1.52 |
For the NTLA stock predictions from the analysts covering Intellia Therapeutics Inc, we have collected all of the individual NTLA stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 24 different analysts covering NTLA (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since NTLA stock predictions may vary widely, another useful metric to consider is the median NTLA stock prediction, which represents the price at which half of the analysts
made NTLA stock predictions that were higher and half made NTLA stock predictions that were lower. This makes for a different take on the NTLA stock predictions out there, as compared to average or mean.
And that median across all the individual NTLA stock predictions was: $57.5 as of 2024-12-03.
The very highest of the NTLA stock predictions for one year price target was $128.0, while the very lowest of the NTLA stock predictions in the analyst group was
$14.0 (with a standard deviation of $28.677). Get the latest Zacks research report on NTLA — FREE
Find out: NTLA next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
DZSI Stock Predictions
ORGO Stock Predictions
FBP Stock Predictions
BL Stock Predictions
TW Stock Predictions
DOYU Stock Predictions
DHT Stock Predictions
FAST Stock Predictions
VIPS Stock Predictions
|
|
Buy (3.48 out of 4) 60th percentile
(ranked higher than approx. 60% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |